{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:49:54Z","timestamp":1792039794094,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V030434\/1"],"award-info":[{"award-number":["MR\/V030434\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s40264-026-01694-2","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:51:19Z","timestamp":1783936279000},"page":"1505-1514","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sexual Dysfunction Among Males Living with HIV Receiving Dolutegravir-Based Antiretroviral Therapy in Uganda: A Cross-sectional Study"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2636-4115","authenticated-orcid":false,"given":"Ronald","family":"Kiguba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishael","family":"Ssesanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Agnes Laker","family":"Odongpiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munir","family":"Pirmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"12","key":"1694_CR1","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1097\/qad.0000000000001845","volume":"32","author":"M Vitoria","year":"2018","unstructured":"Vitoria M, Hill A, Ford N, Doherty M, Clayden P, Venter F, et al. The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries: what are the issues? AIDS. 2018;32(12):1551\u201361. https:\/\/doi.org\/10.1097\/qad.0000000000001845.","journal-title":"AIDS"},{"key":"1694_CR2","unstructured":"World Health Organization: Update of recommendations on first-and second-line antiretroviral regimens. Geneva. https:\/\/www.who.int\/publications\/i\/item\/WHO-CDS-HIV-19.15 (2019). Accessed 6 Mar 2026."},{"issue":"1","key":"1694_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.24875\/AIDSRev.19000023","volume":"21","author":"C Hoffmann","year":"2019","unstructured":"Hoffmann C, Llibre JM. Neuropsychiatric Adverse Events with Dolutegravir and Other Integrase Strand Transfer Inhibitors. AIDS Rev. 2019;21(1):4\u201310. https:\/\/doi.org\/10.24875\/AIDSRev.19000023.","journal-title":"AIDS Rev"},{"issue":"1","key":"1694_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/hiv.12468","volume":"18","author":"C Hoffmann","year":"2017","unstructured":"Hoffmann C, Welz T, Sabranski M, Kolb M, Wolf E, Stellbrink HJ, et al. Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients. HIV Med. 2017;18(1):56\u201363. https:\/\/doi.org\/10.1111\/hiv.12468.","journal-title":"HIV Med"},{"issue":"11","key":"1694_CR5","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.21037\/tau-24-234","volume":"13","author":"S Skura","year":"2024","unstructured":"Skura S, Fontanari AMV, de Azevedo LBH, Bagatini RM, J\u00fanior VS, Benvegn\u00fa DM, et al. Erectile dysfunction in men with human immunodeficiency virus: prevalence and associated factors. Translational Andrology and Urology. 2024;13(11):2396\u2013407. https:\/\/doi.org\/10.21037\/tau-24-234.","journal-title":"Translational Andrology and Urology."},{"issue":"1","key":"1694_CR6","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1186\/s12879-022-07673-z","volume":"22","author":"H Zakumumpa","year":"2022","unstructured":"Zakumumpa H, Kiguba R, Ndagije HB, Ategeka G, Ssanyu JN, Kitutu FE. Patient experiences of sexual dysfunction after transition to dolutegravir-based HIV treatment in mid-Western Uganda: a qualitative study. BMC Infect Dis. 2022;22(1):692. https:\/\/doi.org\/10.1186\/s12879-022-07673-z.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"1694_CR7","doi-asserted-by":"publisher","first-page":"e1761","DOI":"10.1016\/s2214-109x(25)00299-2","volume":"13","author":"R Kiguba","year":"2025","unstructured":"Kiguba R, Ndagije HB, Mwebaza N, Ssenyonga R, Giibwa L, Isabirye G, et al. Adverse drug reaction reporting with the Med Safety app in Uganda: a cluster-randomised, controlled trial. Lancet Glob Health. 2025;13(10):e1761\u201370. https:\/\/doi.org\/10.1016\/s2214-109x(25)00299-2.","journal-title":"Lancet Glob Health"},{"key":"1694_CR8","doi-asserted-by":"publisher","unstructured":"Association AP. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR),. 5th ed. 2022. https:\/\/doi.org\/10.1176\/appi.books.9780890425787.","DOI":"10.1176\/appi.books.9780890425787"},{"issue":"4","key":"1694_CR9","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/hiv.13761","volume":"26","author":"EAL Odongpiny","year":"2025","unstructured":"Odongpiny EAL, Nicol M, Katana E, Owori J, Buzibye A, Sedan K, et al. A programmatic assessment of dolutegravir adverse events and discontinuations in Uganda. HIV Med. 2025;26(4):592\u2013605. https:\/\/doi.org\/10.1111\/hiv.13761.","journal-title":"HIV Med"},{"key":"1694_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10051088","author":"S De Vincentis","year":"2021","unstructured":"De Vincentis S, Tartaro G, Rochira V, Santi D. HIV and Sexual Dysfunction in Men. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10051088.","journal-title":"J Clin Med"},{"issue":"1","key":"1694_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1089\/apc.2006.0071","volume":"21","author":"NF Crum-Cianflone","year":"2007","unstructured":"Crum-Cianflone NF, Bavaro M, Hale B, Amling C, Truett A, Brandt C, et al. Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDS. 2007;21(1):9\u201319. https:\/\/doi.org\/10.1089\/apc.2006.0071.","journal-title":"AIDS Patient Care STDS"},{"issue":"2","key":"1694_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/QAD.0b013e328334444b","volume":"24","author":"O Moreno-P\u00e9rez","year":"2010","unstructured":"Moreno-P\u00e9rez O, Esco\u00edn C, Serna-Candel C, Pic\u00f3 A, Alfayate R, Merino E, et al. Risk factors for sexual and erectile dysfunction in HIV-infected men: the role of protease inhibitors. AIDS. 2010;24(2):255\u201364. https:\/\/doi.org\/10.1097\/QAD.0b013e328334444b.","journal-title":"AIDS"},{"issue":"6","key":"1694_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1089\/apc.2011.0059","volume":"25","author":"AW Shindel","year":"2011","unstructured":"Shindel AW, Horberg MA, Smith JF, Breyer BN. Sexual dysfunction, HIV, and AIDS in men who have sex with men. AIDS Patient Care STDS. 2011;25(6):341\u20139. https:\/\/doi.org\/10.1089\/apc.2011.0059.","journal-title":"AIDS Patient Care STDS"},{"issue":"6","key":"1694_CR14","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/andr.13372","volume":"11","author":"S De Vincentis","year":"2023","unstructured":"De Vincentis S, Decaroli MC, Milic J, Fanelli F, Tartaro G, Diazzi C, et al. Determinants of sexual function in men living with HIV younger than 50 years old: Focus on organic, relational, and psychological issues. Andrology. 2023;11(6):954\u201369. https:\/\/doi.org\/10.1111\/andr.13372.","journal-title":"Andrology"},{"issue":"7","key":"1694_CR15","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1111\/jsm.12175","volume":"10","author":"I De Ryck","year":"2013","unstructured":"De Ryck I, Van Laeken D, Apers L, Colebunders R. Erectile dysfunction, testosterone deficiency, and risk of coronary heart disease in a cohort of men living with HIV in Belgium. J Sex Med. 2013;10(7):1816\u201322. https:\/\/doi.org\/10.1111\/jsm.12175.","journal-title":"J Sex Med"},{"issue":"8","key":"1694_CR16","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1080\/09540120701209847","volume":"19","author":"D Asboe","year":"2007","unstructured":"Asboe D, Catalan J, Mandalia S, Dedes N, Florence E, Schrooten W, et al. Sexual dysfunction in HIV-positive men is multi-factorial: a study of prevalence and associated factors. AIDS Care. 2007;19(8):955\u201365. https:\/\/doi.org\/10.1080\/09540120701209847.","journal-title":"AIDS Care"},{"issue":"11","key":"1694_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/and.14621","volume":"54","author":"EN Akang","year":"2022","unstructured":"Akang EN, Dosumu OO, Ogbenna AA, Akpan UU, Ezeukwu JC, Odofin MO, et al. The impact of dolutegravir-based combination antiretroviral therapy on the spermatozoa and fertility parameters of men living with human immunodeficiency virus. Andrologia. 2022;54(11):e14621. https:\/\/doi.org\/10.1111\/and.14621.","journal-title":"Andrologia"},{"issue":"3","key":"1694_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/09540121.2019.1653443","volume":"32","author":"B Huntingdon","year":"2020","unstructured":"Huntingdon B, Muscat DM, de Wit J, Duracinsky M, Juraskova I. Factors associated with erectile dysfunction among men living with HIV: a systematic review. AIDS Care. 2020;32(3):275\u201385. https:\/\/doi.org\/10.1080\/09540121.2019.1653443.","journal-title":"AIDS Care"},{"issue":"4","key":"1694_CR19","first-page":"731","volume":"33","author":"AH Clayton","year":"1997","unstructured":"Clayton AH, McGarvey EL, Clavet GJ. The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol Bull. 1997;33(4):731\u201345.","journal-title":"Psychopharmacol Bull"},{"key":"1694_CR20","unstructured":"Uganda National Council for Science and TEchnology (UNCST): National Guidelines for Research Involving Humans as Research Participants. https:\/\/www.uncst.go.ug\/files\/downloads\/NATIONAL%20GUIDELINES%20FOR%20RESEARCH%20INVOLVING%20HUMANS%20AS%20RESEARCH%20PARTICPANTS%202025.pdf. 2025. Accessed 13 Mar 2026."},{"issue":"9","key":"1694_CR21","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x.","journal-title":"J Gen Intern Med"},{"key":"1694_CR22","unstructured":"World Health Organisation (WHO): Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. https:\/\/www.who.int\/publications\/i\/item\/definition-and-diagnosis-of-diabetes-mellitus-and-intermediate-hyperglycaemia. 2006. Accessed 13 Mar 2026."},{"key":"1694_CR23","unstructured":"World Health Organisation (WHO): Use of glycated haemoglobin (HbA1c) in diagnosis of diabetes mellitus. https:\/\/www.who.int\/publications\/i\/item\/use-of-glycated-haemoglobin-(-hba1c)-in-diagnosis-of-diabetes-mellitus. 2011. Accessed 13 Mar 2026."},{"issue":"4","key":"1694_CR24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1124\/pr.111.004515","volume":"63","author":"KE Andersson","year":"2011","unstructured":"Andersson KE. Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction. Pharmacol Rev. 2011;63(4):811\u201359. https:\/\/doi.org\/10.1124\/pr.111.004515.","journal-title":"Pharmacol Rev"},{"issue":"4","key":"1694_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s40264-025-01626-6","volume":"49","author":"S Crisafulli","year":"2026","unstructured":"Crisafulli S, Ciccimarra F, Scapini F, L\u2019Abbate L, Jannini EA, De Martino MC, et al. Sexual dysfunctions associated with proton pump inhibitors: insights from VigiBase, the World Health Organization Pharmacovigilance Database. Drug Saf. 2026;49(4):435\u201347. https:\/\/doi.org\/10.1007\/s40264-025-01626-6.","journal-title":"Drug Saf"},{"issue":"4","key":"1694_CR26","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40264-025-01631-9","volume":"49","author":"L Westphal","year":"2026","unstructured":"Westphal L, Gr\u00e4f DD, Le H, Hallgreen CE, Andersen M. Sexual dysfunction in male patients after initiating treatment with antidepressants. Drug Saf. 2026;49(4):493\u2013503. https:\/\/doi.org\/10.1007\/s40264-025-01631-9.","journal-title":"Drug Saf"},{"issue":"4","key":"1694_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/qai.0000000000001269","volume":"74","author":"A Fettiplace","year":"2017","unstructured":"Fettiplace A, Stainsby C, Winston A, Givens N, Puccini S, Vannappagari V, et al. Psychiatric symptoms in patients receiving dolutegravir. J Acquir Immune Defic Syndr. 2017;74(4):423\u201331. https:\/\/doi.org\/10.1097\/qai.0000000000001269.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"1694_CR28","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1086\/382531","volume":"38","author":"E Mart\u00ednez","year":"2004","unstructured":"Mart\u00ednez E, Domingo P, Galindo MJ, Milinkovic A, Arroyo JA, Baldovi F, et al. Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir-ritonavir. Clin Infect Dis. 2004;38(7):1017\u201323. https:\/\/doi.org\/10.1086\/382531.","journal-title":"Clin Infect Dis"},{"issue":"1\u20132","key":"1694_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0021-9681(79)90012-2","volume":"32","author":"DL Sackett","year":"1979","unstructured":"Sackett DL. Bias in analytic research. J Chronic Dis. 1979;32(1\u20132):51\u201363. https:\/\/doi.org\/10.1016\/0021-9681(79)90012-2.","journal-title":"J Chronic Dis"},{"issue":"3","key":"1694_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/s0165-0173(98)00019-8","volume":"28","author":"KC Berridge","year":"1998","unstructured":"Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev. 1998;28(3):309\u201369. https:\/\/doi.org\/10.1016\/s0165-0173(98)00019-8.","journal-title":"Brain Res Brain Res Rev"},{"issue":"Suppl 2","key":"1694_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/s0306-4530(02)00130-0","volume":"28","author":"H Knegtering","year":"2003","unstructured":"Knegtering H, van der Moolen AE, Castelein S, Kluiter H, van den Bosch RJ. What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology. 2003;28(Suppl 2):109\u201323. https:\/\/doi.org\/10.1016\/s0306-4530(02)00130-0.","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"1694_CR32","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/j.1743-6109.2009.01248.x","volume":"6","author":"G Corona","year":"2009","unstructured":"Corona G, Ricca V, Bandini E, Mannucci E, Lotti F, Boddi V, et al. Selective serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Med. 2009;6(5):1259\u201369. https:\/\/doi.org\/10.1111\/j.1743-6109.2009.01248.x.","journal-title":"J Sex Med"},{"key":"1694_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijans.2024.100791","volume":"21","author":"M Golshekan","year":"2024","unstructured":"Golshekan M, Abedinzade M, Bostani Khalesi Z, Shayesteh FM. Predictors of erectile dysfunction in men living with HIV: a systematic review update. Int J Afr Nurs Sci. 2024;21:100791. https:\/\/doi.org\/10.1016\/j.ijans.2024.100791.","journal-title":"Int J Afr Nurs Sci"},{"issue":"2","key":"1694_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/andr.70050","volume":"14","author":"G Tiecco","year":"2026","unstructured":"Tiecco G, Delbarba A, Colangelo C, Di Gregorio M, Facondo P, Riva M, et al. Penile vascular status in young men living with HIV experiencing erectile dysfunction: a comparative cross-sectional pilot study. Andrology. 2026;14(2):377\u201384. https:\/\/doi.org\/10.1111\/andr.70050.","journal-title":"Andrology"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-026-01694-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-026-01694-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-026-01694-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:42:29Z","timestamp":1792039349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-026-01694-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1694"],"URL":"https:\/\/doi.org\/10.1007\/s40264-026-01694-2","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.P. currently receives partnership funding, paid to the University of Liverpool, for the MRC Medicines Development Fellowship Scheme (co-funded by MRC and GSK, AZ, Optum and Hammersmith Medicines Research). He has developed an HLA genotyping panel with MC Diagnostics but does not benefit financially from this. He is part of the IMI Consortium ARDAT (\n                      \n                      ); none of these funding sources have been used for the current research. M.P. is an Editorial Board member of\n                      Drug Safety\n                      . M.P. was not involved in the selection of peer reviewers for the manuscript nor in any of the subsequent editorial decisions.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RK supervised the study and conceived the concept in concert with MS and MP. RK and MS wrote the first draft of the manuscript. RK and MS conducted the analyses. RK, MS, EALO and MP critically revised the manuscript and made important intellectual contributions. The corresponding author (RK) attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted. All authors read and approved the final version.","order":2,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the School of Biomedical Sciences Research and Ethics Committee, Makerere University (SBS-2022-262) and Uganda\u2019s National Council for Science and Technology (HS3364ES).","order":3,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent.","order":4,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data that support the findings are available on reasonable request from the corresponding author.","order":6,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The code used in data extraction and analysis is available upon reasonable request.","order":7,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}}]}}